CERN Accelerating science

Published Articles
Title First laser ions at the CERN-MEDICIS facility
Author(s)

Gadelshin, Vadim Maratovich (Mainz U., Inst. Phys. ; Urals State U.) ; Wilkins, Shane (CERN) ; Fedosseev, Valentin Nikolaevich (CERN) ; Barbero, Ermanno (CERN) ; Barozier, Vincent (CERN) ; Bernardes, Ana-Paula (CERN) ; Chevallay, Eric (CERN) ; Cocolios, Thomas Elias (Leuven U.) ; Crepieux, Bernard (CERN) ; Dockx, Kristof (Leuven U.) ; Eck, Matthias (Leuven U.) ; Fernier, Pascale (CERN) ; Cavaier, Roberto Formento (Unlisted, IT) ; Haddad, Ferid (GIP ARRONAX ; SUBATECH, Nantes) ; Jakobi, Johannes (Mainz U., Inst. Phys.) ; Lambert, Laura (CERN) ; Marsh, Bruce Allan (CERN) ; Marzari, Stefano (CERN) ; Ramos, Joao Pedro (CERN ; Leuven U.) ; Moberg, Annie Ringvall (CERN ; U. Gothenburg (main)) ; Rothe, Sebastian (CERN) ; Stora, Thierry (CERN) ; Studer, Dominik (Mainz U., Inst. Phys.) ; Suarez, Andres Vieitez (CERN) ; Weber, Felix (Mainz U., Inst. Phys.) ; Wendt, Klaus (Mainz U., Inst. Phys.)

Publication 2020
Number of pages 9
In: Hyperfine Interact. 241 (2020) 55
DOI 10.1007/s10751-020-01718-y
Subject category Other
Accelerator/Facility, Experiment CERN MEDICIS
Abstract The CERN-MEDICIS facility aims to produce emerging medical radionuclides for the theranostics approach in nuclear medicine with mass separation of ion beams. To enhance the radioisotope yield and purity of collected samples, the resonance ionization laser ion source MELISSA was constructed, and provided the first laser ions at the facility in 2019. Several operational tests were accomplished to investigate its performance in preparation for the upcoming production of terbium radioisotopes, which are of particular interest for medical applications.
Copyright/License © The Author(s) 2020 (License: CC-BY-4.0)

Corresponding record in: Inspire


 Zapis kreiran 2020-09-02, zadnja izmjena 2020-09-02


Cjeloviti tekst:
Download fulltext
PDF